Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — GMED

Balance Sheet

(in billions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Cash & Equivalents	0.51	0.56	0.53	0.37	0.23	0.46	0.78	0.62	0.41	0.35	0.47	0.28	0.31	0.22	0.15	0.13	0.15	0.23	0.19	0.36
Short-term Investments	0.09	0.07	0.03	0.02	--	0.11	0.11	0.07	0.08	0.08	0.05	0.19	0.31	0.29	0.30	0.27	0.26	0.24	0.25	0.19
Accounts Receivable	0.69	0.69	0.68	0.62	0.61	0.54	0.56	0.59	0.61	0.53	0.50	0.49	0.24	0.22	0.21	0.21	0.19	0.17	0.16	0.16
Inventory	0.81	0.77	0.76	0.77	0.77	0.66	0.66	0.72	0.77	0.82	0.85	0.90	0.34	0.32	0.30	0.28	0.27	0.25	0.24	0.23
Total Current Assets	2.22	2.20	2.13	1.92	1.73	1.71	2.18	2.06	1.92	1.83	1.92	1.92	1.21	1.07	0.98	0.92	0.89	0.92	0.86	0.98
Property, Plant & Equipment	0.53	0.56	0.56	0.58	0.59	0.56	0.56	0.57	0.57	0.58	0.59	0.61	0.25	0.25	0.24	0.24	0.24	0.23	0.22	0.22
Goodwill	1.44	1.44	1.44	1.43	1.43	1.43	1.43	1.43	1.45	1.45	1.43	1.12	0.20	0.20	0.20	0.18	0.18	0.18	0.18	0.17
Intangible Assets	0.69	0.72	0.75	0.77	0.80	0.77	0.80	0.84	0.87	0.89	0.92	1.26	0.05	0.06	0.06	0.05	0.06	0.06	0.07	0.07
Total Non-current Assets*	3.27	3.24	0.56	0.58	0.59	0.56	0.57	0.57	0.57	0.58	0.59	0.61	1.00	1.08	1.09	1.06	1.02	1.08	1.09	0.93
Total Assets	5.49	5.44	5.30	5.10	4.96	4.71	5.25	5.09	4.99	4.94	5.09	5.36	2.21	2.15	2.08	1.98	1.91	2.00	1.96	1.91
Accounts Payable	0.11	0.10	0.10	0.09	0.09	0.07	0.08	0.06	0.07	0.05	0.06	0.09	0.03	0.04	0.04	0.03	0.03	0.03	0.02	0.02
Total Current Liabilities	0.48	0.48	0.50	0.47	0.42	0.38	0.86	0.82	0.79	0.79	0.39	0.43	0.16	0.17	0.16	0.15	0.15	0.14	0.14	0.12
Total Non-current Liabilities*	0.24	0.22	0.23	0.23	0.24	0.24	0.22	0.20	0.22	0.23	0.70	0.74	0.07	0.07	0.07	0.07	0.07	0.07	0.08	0.07
Total Liabilities	0.72	0.71	0.73	0.70	0.67	0.62	1.07	1.02	1.02	1.02	1.09	1.17	0.23	0.23	0.23	0.21	0.22	0.21	0.22	0.19
Retained Earnings	1.53	1.51	1.39	1.29	1.21	1.04	1.15	1.13	1.07	1.05	1.14	1.35	1.35	1.29	1.24	1.19	1.14	1.23	1.19	1.18
Total Stockholder Equity	4.77	4.73	4.57	4.40	4.30	4.09	4.18	4.07	3.98	3.92	4.00	4.19	1.99	1.91	1.85	1.76	1.70	1.79	1.74	1.72

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	789.61	759.85	826.42	769.05	745.34	598.12	657.29	625.71	629.69	606.67	616.53	383.64	291.62	276.69	274.50	254.15	263.65	230.55	250.02	229.72
Cost of Revenue	241.44	234.07	261.11	252.53	248.77	195.40	263.44	270.52	260.04	241.49	265.49	135.39	76.47	70.83	70.59	65.50	68.47	59.17	61.80	58.55
Gross Profit*	548.17	525.79	565.31	516.52	496.58	402.72	393.86	355.19	369.65	365.18	351.05	248.25	215.14	205.86	203.91	188.65	195.18	171.38	188.23	171.17
Research & Development	36.32	36.51	36.16	38.07	39.95	33.06	33.41	35.38	37.70	57.27	52.25	29.33	21.35	21.08	19.51	18.70	17.40	17.41	51.02	15.85
Selling, General & Admin	286.82	297.77	318.48	313.60	303.62	242.80	253.48	240.74	238.12	248.71	244.72	156.21	120.07	122.42	118.08	106.58	106.72	100.75	106.56	96.44
Total Operating Expenses*	365.74	375.40	395.97	379.15	420.47	305.72	333.58	307.09	320.03	357.18	340.93	247.85	148.93	149.46	149.88	128.95	127.40	124.94	170.03	117.84
Operating Income	182.43	150.39	169.34	137.36	76.11	97.00	60.27	48.10	49.62	8.00	10.12	0.40	66.21	56.40	54.03	59.70	67.78	46.45	18.20	53.33
Pretax Income	189.82	157.07	169.23	143.99	188.17	103.67	24.67	57.03	47.58	(8.56)	25.00	2.54	74.67	63.19	62.12	61.47	70.54	48.90	19.83	54.45
Tax Provision	38.25	32.77	28.64	25.03	(14.67)	28.21	(1.84)	5.20	15.82	(1.44)	9.96	1.54	16.96	14.06	12.05	14.03	15.95	10.81	4.72	7.24
Net Income	151.57	124.30	140.59	118.97	202.85	75.46	26.51	51.84	31.76	(7.12)	15.03	1.00	57.71	49.13	50.06	47.43	54.59	38.08	15.11	47.21
Basic EPS	1.12	0.92	1.05	0.88	1.50	0.55	0.20	0.38	0.23	(0.05)	0.02	0.01	0.57	0.49	0.50	0.48	0.54	0.37	0.15	0.47
Diluted EPS	1.10	0.90	1.01	0.88	1.49	0.54	0.19	0.38	0.23	(0.05)	0.01	0.01	0.57	0.48	0.48	0.47	0.53	0.37	0.15	0.45

← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	209.74	202.36	248.59	249.70	77.86	177.30	210.34	203.65	54.26	52.39	104.67	50.48	35.03	53.31	63.98	32.92	36.88	44.69	76.25	77.26
Capital Expenditures	33.17	39.62	46.20	35.82	46.56	36.10	17.11	41.95	27.80	28.57	22.88	21.53	17.87	15.99	18.34	11.98	23.75	19.97	17.05	17.80
Free Cash Flow*	176.57	162.75	202.39	213.88	31.30	141.20	193.23	161.70	26.46	23.82	81.79	28.95	17.16	37.32	45.64	20.94	13.13	24.72	59.21	59.47
Investing Cash Flow	(129.05)	(182.67)	(111.45)	(75.84)	(299.11)	131.39	(104.12)	(14.97)	(10.38)	(46.58)	320.62	(80.86)	52.22	10.99	(60.48)	(63.11)	27.13	(13.89)	(243.80)	(6.88)
Financing Cash Flow	(134.50)	18.20	13.22	(32.04)	(24.94)	(635.40)	59.73	19.58	8.71	(115.72)	(237.27)	1.43	1.08	2.94	13.59	13.16	(142.76)	6.05	(1.02)	22.68

← Scroll for more columns →

* Derived from reported values